Skip to content
★ Sign in to follow
GB

Graham Burton

Celgene Corp /DE/
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€2.1M

Latest filing published 16 Sept 2011 for CELGENE CORP /DE/, €219k.

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

No signal scores available.

Graham Burton: trading record in brief

All filings by Graham Burton on record concern Celgene Corp /DE/. The record holds 19 filings, for trades running from 14 March 2008 to 15 September 2011.

Sales make up the whole of the open-market record (3 sales, €2.1M). Other entries cover 8 share grants and 8 option exercises. So far in 2011, the count stands at no purchases and 1 sale.

The latest filing, published on 16 September 2011, reports an open-market sale of €219k in Celgene Corp /DE/. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Graham Burton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total
  • ▼
    See RemarksExecutivesCelgene Corp /DE/
    303,800 USD0SEC
    5,000 shares@ US$60.76Common StockSEC:0001104659-11-052103:0
  • ◇
    See RemarksExecutivesCelgene Corp /DE/
    15,560 USD0SEC
    2,000 shares@ US$7.78Common StockSEC:0001104659-11-052103:1
  • ◆
    See RemarksExecutivesCelgene Corp /DE/
    15,505 USD0SEC
    257 shares@ US$60.33Common StockSEC:0001104659-11-052103:2
  • ▼
    See RemarksExecutivesCelgene Corp /DE/
    632,800 USD0SEC
    10,000 shares@ US$63.28Common StockSEC:0001209191-10-053186:0
  • ◇
    See RemarksExecutivesCelgene Corp /DE/
    8,736 USD0SEC
    1,200 shares@ US$7.28Common StockSEC:0001209191-10-053186:1
  • ◆
    See RemarksExecutivesCelgene Corp /DE/
    9,317 USD0SEC
    148 shares@ US$62.95Common StockSEC:0001209191-10-053186:2
  • ▼
    See RemarksExecutivesCelgene Corp /DE/
    2M USD0SEC
    39,639 shares@ US$52.23Common StockSEC:0001209191-09-050124:0
  • ◇
    See RemarksExecutivesCelgene Corp /DE/
    7,780 USD0SEC
    1,000 shares@ US$7.78Common StockSEC:0001209191-09-031408:0
  • ◆
    See RemarksExecutivesCelgene Corp /DE/
    7,761 USD0SEC
    175 shares@ US$44.35Common StockSEC:0001209191-09-031408:1
  • ◇
    See RemarksExecutivesCelgene Corp /DE/
    147,236 USD0SEC
    11,248 shares@ US$13.09Common StockSEC:0001209191-09-031408:2
  • ◆
    See RemarksExecutivesCelgene Corp /DE/
    302,689 USD0SEC
    6,825 shares@ US$44.35Common StockSEC:0001209191-09-031408:3
  • ◇
    See RemarksExecutivesCelgene Corp /DE/
    161,537 USD0SEC
    11,408 shares@ US$14.16Common StockSEC:0001209191-09-031408:4
  • ◆
    See RemarksExecutivesCelgene Corp /DE/
    286,678 USD0SEC
    6,464 shares@ US$44.35Common StockSEC:0001209191-09-031408:5
  • ◇
    Sr VP, GRA & PharmacovigilanceExecutivesCelgene Corp /DE/
    528,138 USD0SEC
    67,884 shares@ US$7.78Common StockSEC:0001209191-08-059140:0
  • ◆
    Sr VP, GRA & PharmacovigilanceExecutivesCelgene Corp /DE/
    2M USD0SEC
    35,809 shares@ US$65.23Common StockSEC:0001209191-08-059140:1
  • ◇
    Sr VP, GRA & PharmacovigilanceExecutivesCelgene Corp /DE/
    168,150 USD0SEC
    15,000 shares@ US$11.21Common StockSEC:0001209191-08-059140:2
  • ◆
    Sr VP, GRA & PharmacovigilanceExecutivesCelgene Corp /DE/
    543,627 USD0SEC
    8,334 shares@ US$65.23Common StockSEC:0001209191-08-059140:3
  • ◇
    Sr. Vice President, GRA&PExecutivesCelgene Corp /DE/
    409,905 USD0SEC
    52,687 shares@ US$7.78Common StockSEC:0001209191-08-018910:0
  • ◆
    Sr. Vice President, GRA&PExecutivesCelgene Corp /DE/
    2M USD0SEC
    27,599 shares@ US$56.30Common StockSEC:0001209191-08-018910:1

19 of 19 declarations